 Home > Medical News > Medicines Company News > CStone Pharmaceuticals announced the updated data of the registered clinical study of sugarizumab in the treatment of stage IV non-small cell lung cancer in the form of an oral report at the 2021 World Lung Cancer Conference

CStone Pharmaceuticals announced the updated data of the registered clinical study of sugarizumab in the treatment of stage IV non-small cell lung cancer in the form of an oral report at the 2021 World Lung Cancer Conference

 Last Update: 2021-09-18
 Source: Internet
 Author: User

Tags

what dna analysis

cell number

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Conference topic: Immunotherapy
Conference theme: Carrying on the past, what will be the next immunotherapy combination?
Date: 08:10, September 14, 2021 (Beijing time)
Report format: oral report
Title: GEMSTONE-302: A randomized, double-blind, phase III study comparing sugarizumab combined with platinum-based chemotherapy and placebo combined with platinum-based chemotherapy in the first-line treatment of patients with metastatic non-small cell lung cancer
Report number: MA13.
- The median PFS assessed by the researchers was 9.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.